Volume 20 Issue 7
Jul.  2022
Turn off MathJax
Article Contents
HU Fang-ying, FANG Hong-wei, LIN Ping, ZHANG Qiu-shi, MA Jing, CHEN Yue-fang. Study on the effect of increased creatinine level after antihypertensive treatment on the risk of cardiovascular events in patients[J]. Chinese Journal of General Practice, 2022, 20(7): 1147-1150. doi: 10.16766/j.cnki.issn.1674-4152.002544
Citation: HU Fang-ying, FANG Hong-wei, LIN Ping, ZHANG Qiu-shi, MA Jing, CHEN Yue-fang. Study on the effect of increased creatinine level after antihypertensive treatment on the risk of cardiovascular events in patients[J]. Chinese Journal of General Practice, 2022, 20(7): 1147-1150. doi: 10.16766/j.cnki.issn.1674-4152.002544

Study on the effect of increased creatinine level after antihypertensive treatment on the risk of cardiovascular events in patients

doi: 10.16766/j.cnki.issn.1674-4152.002544
Funds:

 2020KY724

  • Received Date: 2021-09-01
    Available Online: 2022-09-23
  •   Objective  Decreased renal function associated with renin-angiotensin inhibitors in antihypertensive therapy is associated with an increased risk of cardiovascular disease. However, few studies on other antihypertensive drugs are available. This study aimed to investigate the incidence of cardiovascular events associated with elevated plasma creatinine following first-line antihypertensive medication.  Methods  A total of 182 patients with hypertension who visited Hangzhou Third People's Hospital from October 2015 to June 2020 were enrolled, including 96 males and 86 females, aged (60.5±6.4) years. All patients received renin-angiotensin inhibitors, calcium channel blockers or thiazide antihypertensives during this time period. The correlation between the incidence of 6-month cardiovascular events (ischemic cardiomyopathy, heart failure or stroke) and elevated creatinine was explored.  Results  In accordance with creatinine level, the patients were divided into group A (0%-9%, 79 cases), group B (10%-19%, 40 cases), group C (20%-29%, 27 cases), group D (30%-39%, 20 cases) and group E (>40%, 16 cases). Amongst them, 43.4% (79/182) of patients had an elevated creatinine level of 0%-9%. Six cardiovascular events (3.3%) occurred during the 6-month follow-up period, and no patient died. The creatinine elevations of 0%-9% and 30%-39% corresponded to 6-month cardiovascular event rates of 0.6% and 3.4%, respectively. The total follow-up time was 3.1 (1.8, 5.8) years, the overall incidence of cardiovascular events was 8.2% (15/182) and the incidence in groups D and E was significantly higher than that in other groups (P < 0.001). Higher age and reduced renal function were strongly associated with increased odds of cardiovascular events but not with type of antihypertensive medication.  Conclusion  A greater than 30% increase in plasma creatinine levels in patients starting first-line antihypertensive therapy in primary prevention is associated with increased short-term (6 months) and long-term (3 years) incidence of cardiovascular events.

     

  • loading
  • [1]
    BAKRIS G L, AGARWAL R. Creatinine bump following antihypertensive therapy[J]. Hypertension, 2018, 72(6): 1274-1276. doi: 10.1161/HYPERTENSIONAHA.118.12051
    [2]
    蒋小菊, 赵印平, 刘卫华, 等. 高血压患者血管病变及心脏重构与尿微量白蛋白/肌酐关系的研究[J]. 中国社区医师, 2018, 34(15): 132-133, 135. doi: 10.3969/j.issn.1007-614x.2018.15.082

    JIANG X J, ZHAO Y P, LIU WH, et al. Study on the relationship between vascular disease and cardiac remodeling and urinary microalbumin/creatinine in patients with hypertension[J]. Chinese Community Physician, 2018, 34(15): 132-133, 135. doi: 10.3969/j.issn.1007-614x.2018.15.082
    [3]
    PALMER S C, RUOSPO M, TEIXEIRA-PINTO A, et al. The validity of drug effects on proteinuria, albuminuria, serum creatinine, and estimated GFR as surrogate end points for ESKD: A systematic review[J]. Am J Kidney Dis, 2018, 72(6): 779-789. doi: 10.1053/j.ajkd.2018.06.011
    [4]
    卢湘鸿, 李翔, 张军. 血浆内皮素-1水平及晨尿白蛋白/肌酐比值与高血压及血压变异的相关性[J]. 临床医药文献电子杂志, 2018, 5(5): 15-16. doi: 10.3877/j.issn.2095-8242.2018.05.011

    LU X H, LI X, ZHANG J. Correlation of plasma endothelin-1 level and morning urine albumin/creatinine ratio with hypertension and blood pressure variability[J]. Electronic Journal of Clinical Medicine, 2018, 5(5): 15-16. doi: 10.3877/j.issn.2095-8242.2018.05.011
    [5]
    王胜煌. 《ISH2020国际高血压实践指南》解析与宁波实践分享[J]. 中华医学信息导报, 2020, 35(13): 17. doi: 10.3760/cma.j.issn.1000-8039.2020.13.130

    WANG S H. "ISH2020 International Hypertension Practice Guidelines" Analysis and Ningbo Practice Sharing[J]. China Medical Information Herald, 2020, 35(13): 17. doi: 10.3760/cma.j.issn.1000-8039.2020.13.130
    [6]
    李智. 高血压并发脑出血尼卡地平治疗期间血钙和血肌酐水平的变化及意义[J]. 北方药学, 2018, 15(6): 72-73. doi: 10.3969/j.issn.1672-8351.2018.06.057

    LI Z. Changes and significance of serum calcium and serum creatinine levels during nicardipine treatment with hypertension complicated with cerebral hemorrhage[J]. Northern Pharmacy, 2018, 15(6): 72-73. doi: 10.3969/j.issn.1672-8351.2018.06.057
    [7]
    刘张玲, 蒲然, 刘霞, 等. 胱抑素C、同型半胱氨酸、尿微量清蛋白/肌酐比值联合检测在高血压早期肾损害诊断中的价值[J]. 现代医药卫生, 2019, 35(7): 1011-1013. doi: 10.3969/j.issn.1009-5519.2019.07.014

    LIU Z L, PU R, LIU X, et al. The value of combined detection of cystatin C, homocysteine, and urine microalbumin/creatinine ratio in the diagnosis of early renal damage in hypertension[J]. Modern Medicine and Health, 2019, 35(7): 1011-1013. doi: 10.3969/j.issn.1009-5519.2019.07.014
    [8]
    BARZILAY J I, DAVIS B R, PRESSEL S L, et al. The effects of eGFR change on CVD, renal, and mortality outcomes in a hypertensive cohort treated with 3 different antihypertensive medications[J]. Am J Hypertens, 2018, 31(5): 609-614. doi: 10.1093/ajh/hpx223
    [9]
    周建妹, 陈进, 邓冰莹, 等. 高血压患者血清同型半胱氨酸水平与肌酐、尿酸、甲状旁腺激素的关系[J]. 心脑血管病防治, 2018, 18(5): 394-395, 398. doi: 10.3969/j.issn.1009-816x.2018.05.012

    ZHOU J M, CHEN J, DENG B Y, et al. The relationship between serum homocysteine levels and creatinine, uric acid, and parathyroid hormone in patients with hypertension[J]. Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, 2018, 18(5): 394-395, 398. doi: 10.3969/j.issn.1009-816x.2018.05.012
    [10]
    DAMMAN K, GORI M, CLAGGETT B, et al. Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure[J]. JACC Heart Fail, 2018, 6(6): 489-498. doi: 10.1016/j.jchf.2018.02.004
    [11]
    PARVANOVA A, TRILLINI M, PODESTA M A, et al. Blood pressure and metabolic effects of acetyl-l-carnitine in type 2 diabetes: DIABASI randomized controlled trial[J]. J Endocr Soc, 2018, 2(5): 420-436. doi: 10.1210/js.2017-00426
    [12]
    李志强, 傅咏华, 王春燕, 等. 联合多项自检参数对慢性心力衰竭患者管理的作用[J]. 中华全科医学, 2018, 16(7): 1128-1132. doi: 10.16766/j.cnki.issn.1674-4152.000311

    LI Z Q, FU Y H, WANG C Y, et al. Effect of combined multiple self-check parameters on management of patients with chronic heart failure[J]. Chinese Journal of General Practice, 2018, 16(7): 1128-1132. doi: 10.16766/j.cnki.issn.1674-4152.000311
    [13]
    KIANBAKHT S, HASHEM-DABAGHIAN F. Antihypertensive efficacy and safety of Vaccinium arctostaphylos berry extract in overweight/obese hypertensive patients: A randomized, double-blind and placebo-controlled clinical trial[J]. Complement Ther Med, 2019, 44: 296-300. doi: 10.1016/j.ctim.2019.05.010
    [14]
    张丽娜, 杨苗苗, 王雁良, 等. 尿白蛋白/肌酐比值与原发性高血压患者临床特征的相关性分析[J]. 中华实用诊断与治疗杂志, 2019, 33(8): 816-818. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201908027.htm

    ZHANG L N, YANG M M, WANG Y L, et al. Correlation between urinary albumin/creatinine ratio and clinical characteristics of primary hypertension[J]. Journal of Chinese Practical Diagnosis and Therapy, 2019, 33(8): 816-818. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201908027.htm
    [15]
    张红玉, 谢席胜, 冯胜刚, 等. 慢性肾脏病高血压患者夜间高血压患病率及影响因素[J]. 西部医学, 2020, 32(1): 125-129. doi: 10.3969/j.issn.1672-3511.2020.01.029

    ZHANG H Y, XIE X S, FENG S G, et al. Prevalence and influencing factors of night time hypertension in patients with chronic kidney disease and hypertension[J]. Medical Journal of West China, 2020, 32(1): 125-129. doi: 10.3969/j.issn.1672-3511.2020.01.029
    [16]
    OHKUMA T, JUN M, RODGERS A, et al. Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus[J]. Hypertension, 2019, 73(1): 84-91. doi: 10.1161/HYPERTENSIONAHA.118.12060
    [17]
    FUJIWARA T, YANO Y, HOSHIDE S, et al. Association between change in central nocturnal blood pressure and urine albumin-creatinine ratio by a valsartan/amlodipine combination: A CPET study[J]. Am J Hypertens, 2018, 31(9): 995-1001. doi: 10.1093/ajh/hpy078
    [18]
    吕良冬, 宋瑞芳, 王永光, 等. 血肌酐正常冠心病患者危险因素分析及血清胱抑素C检测意义[J]. 中华全科医学, 2017, 15(9): 1626-1628. doi: 10.16766/j.cnki.issn.1674-4152.2017.09.052

    LV L D, SONG R F, WANG Y G, et al. Analysis of risk factors and significance of serum cystatin C detection in patients with coronary heart disease with normal serum creatinine[J]. Chinese Journal of General Practice, 2017, 15(9): 1626-1628. doi: 10.16766/j.cnki.issn.1674-4152.2017.09.052
    [19]
    COLLARD D, BROUWER T F, PETERS R J G, et al. Creatinine rises during blood pressure therapy and the risk of adverse clinical outcomes in patients with type 2 diabetes mellitus[J]. Hypertension, 2018, 72(6): 1337-1344. doi: 10.1161/HYPERTENSIONAHA.118.11944
    [20]
    余信强, 张苏川. 原发性高血压病人早期肾损伤影响因素的临床研究[J]. 蚌埠医学院学报, 2019, 44(2): 167-170. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201902009.htm

    YU X Q, ZHANG S C. Study on the influencing factor of early renal damage in patients with primary hypertension[J]. Journal of Bengbu Medical College, 2019, 44(2): 167-170. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201902009.htm
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (269) PDF downloads(9) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return